FDA одобрила liraglutide для лечения ожирения
Добавлено: Пт дек 26, 2014 11:41 pm
FDA Approves New Weight-Management Drug
December 24, 2014
The US Food and Drug Administration (FDA) has approved liraglutide (rDNA origin [Saxenda]) injection as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity.
The drug is approved for use in adults with a body mass index (BMI) of ≥30 or adults with a BMI of ≥27 who have at least 1 weight-related condition such as hypertension, type 2 diabetes or dyslipidaemia.
http://dgnews.docguide.com/fda-approves ... newsletter
December 24, 2014
The US Food and Drug Administration (FDA) has approved liraglutide (rDNA origin [Saxenda]) injection as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity.
The drug is approved for use in adults with a body mass index (BMI) of ≥30 or adults with a BMI of ≥27 who have at least 1 weight-related condition such as hypertension, type 2 diabetes or dyslipidaemia.
http://dgnews.docguide.com/fda-approves ... newsletter